10 Most Shorted Mid-Cap and Small-Cap Stocks to Buy Now
Small cap and mid cap stocks have been on a roll in the first half of the year as investors rotate away from mega cap tech stocks.
Posts Tagged ‘NASDAQ:CRSP’
10 Under-the-Radar Stocks with Massive Upside for 2026
As of May 22, 2026, the S&P 500 stood close to its all-time high, up more than 9% for the year after eight consecutive weekly gains, per Reuters.
10 Best ARK Stocks to Buy Right Now
On January 15, Cathie Wood, in her Outlook for 2026, said that the US economy has formed a "coiled spring," referencing ARK Investment Management analysis.
10 Best European Growth Stocks to Buy
European growth stocks are getting another look as investors search for earnings growth outside the usual U.S. mega-cap playbook.
CRISPR (CRSP) Rated Overweight on Gene Editing Growth
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years.
10 Stocks That Could 10X Over the Next 10 Years
The last few years have been incredible for stock investors, with the S&P 500 returning 86% between 2023 and 2025.
Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now?
Biotech company Crispr Therapeutics Ag (NASDAQ:CRSP) shares are up 16% over the past 12 months.
Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy
Ark Invest CEO Cathie Wood quickly became a Wall Street favorite back in the pandemic days with her disruptive investing and impressive returns.
CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth
CRISPR Therapeutics (NASDAQ:CRSP) is one of the best stocks for 20 years.
Long-Term Stock Portfolio: 15 Best Stocks for 20 Years
On March 9, Mohamed El-Erian, The Wharton School Rene Kern Professor & Allianz Chief Economic Advisor, joined 'Squawk Box' on CNBC to discuss the latest market trends, the impact...
Here is Why CRISPR Therapeutics (CRSP) Appears so Good
The firm updated its estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) and evaluated additional pipeline advancements after its partner Vertex Pharmaceuticals (VRTX) disclosed...
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds
On February 5, J.P. Morgan shared its views on trends that are expected to define healthcare in 2026.
CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street
Earlier on February 17, Chardan Capital lifted its price target on CRISPR Therapeutics AG (NASDAQ:CRSP) to $76 from $74 and maintained a Buy rating.
ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026
ARK Investment Management LLC, or ARK Invest, is an American investment management firm that oversees several actively managed ETFs.
Here’s What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the top gene therapy stocks to buy according to hedge funds.
Top 10 Gene Therapy Stocks to Buy According to Hedge Funds
On February 23, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and tariff uncertainties.
Citizens Maintains Outperform Rating On CRISPR Therapeutics (CRSP) Citing Undervalued Pipeline
CRISPR Therapeutics (NASDAQ:CRSP) is one of the stocks that should double by 2030.
15 Stocks That Should Double by 2030
On January 27, Sherry Paul, Morgan Stanley senior portfolio manager, joined CNBC's 'Closing Bell' to discuss the state of equity markets and whether more volatility is ahead.
BofA is Bullish on CRISPR Therapeutics AG (CRSP)
On January 22, 2026, TheFly disclosed that Alec Stranahan, a BofA analyst.
Growth Stock Portfolio: 12 Stock Picks By Cathie Wood
After a severe 2022 decline, Cathie Wood's flagship innovation fund witnessed a dramatic comeback through 2025, climbing 87.1% in the year ending in September 2025 and tripling...
Chardan Maintains A Buy Recommendation On CRISPR Therapeutics AG (CRSP)
TheFly published on November 26, 2025, that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while reducing its price target from $82 to $74.
Contrarius Global Equity Fund’s Thoughts on CRISPR Therapeutics’ (CRSP) Gene Editing Therapy
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the “Contrarius Global Equity Fund”.
12 Best Genomics Stocks to Invest In
Companies that study DNA to improve people's lives are known as genomics stocks.
CRISPR Therapeutics Reports Strong 90% Response Rate and Lupus Remission in Landmark Zugo-Cel Update
CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in.
12 Best Emerging Technology Stocks to Invest In
On December 24, Kevin Simpson of Capital Wealth Planning joined 'Closing Bell' on CNBC to talk about AI tailwinds and the diverging tech picture.
What CRISPR Therapeutics’ (CRSP) Latest Trial Results Mean for Investors
CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Wood’s stock portfolio.
Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now.
Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy
Catherine “Cathie” Wood has been leading the investment management firm ARK Investment Management LLC ("ARK Invest") as its Founder, CEO, and CIO for nearly 15 years.
12 Best Short Squeeze Stocks to Buy Right Now
As the year comes to a close, investors are keeping close tabs on the Federal Reserve's impending policy move, given the US shutdown-induced data shortage.
Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the most oversold biotech stocks to invest in.
9 Oversold Biotech Stocks to Invest In
Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value and healthcare.
RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50, Keeps Sector Perform
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds.
9 Best Gene-Editing Stocks to Buy According to Hedge Funds
Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.
BMO Reaffirms Outperform on CRISPR Therapeutics (CRSP) After Sirius Collaboration
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best biotech stocks to buy.
H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics AG (CRSP) Stock
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the Unstoppable Stocks to Buy and Hold for the Next 5 Years. On September 23, analyst Mitchell Kapoor from H.C.
10 Unstoppable Stocks to Buy and Hold for the Next 5 Years
As per Ajay Rajadhyaksha, Global Chairman of Research at Barclays, the US job growth has slowed, and China’s economic data have demonstrated weakness.
14 Best Biotech Stocks to Buy Right Now
The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.
CRISPR (CRSP) Gains Analyst Support on Sales Momentum and Pipeline Expansion
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now.
11 Best Emerging Technology Stocks to Buy Right Now
While the telephone brought comfort, smartphones changed lives. While factories powered economies, artificial intelligence began rewriting them.
CRISPR Therapeutics AG (CRSP)’s Casgevy Expands Global Adoption in 2025
CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneering biotech company focused on gene-editing medicines using CRISPR/Cas9 technology.
11 Best Performing Biotech Stocks So Far in 2025
On July 8, Jared Holz of Mizuho spoke on CNBC's "Closing Bell Overtime" about whether the biotech sector is ready for a breakthrough.
H.C. Wainwright Lifts CRISPR Therapeutics’ (CRSP) Price Target on CASGEVy Sales Growth
CRISPR Therapeutics AG (NASDAQ:CRSP) in Cathie Wood's Stock Portfolio is one of the top 10 stocks to buy now. On August 7, analysts at H.C.
Cathie Wood Stock Portfolio: Top 10 Stocks to Buy Now
Cathie Wood, the CEO and chief investment officer of ARK Investment Management, has established a reputation thanks to high-conviction bets that often yield significant returns...
What Makes Crispr Therapeutics Ag (CRSP) a Good Buy?
RGA Investment Advisors, an investment management company, has released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Weighed in on These 17 Stocks
“Sometimes you just can't pin a market down. You see things that are so solid, real companies doing real things and getting rewarded for them.
CRISPR Therapeutics (CRSP) Soars 18% After $51-Million Insider Trading
CRISPR Therapeutics soared by 18.22 percent on Friday to close at $65.13 apiece to hit a new all-time high as investors took path from a recent insider trading that gobbled up...
CRISPR Therapeutics (CRSP) Jumps 9.6% on Biotech Rally
During the session, the biotechnology industry rose by 3.58 percent amid a flurry of developments in the sector.
H.C. Wainwright Reaffirms Buy Rating on CRISPR Therapeutics After CTX310 Update
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best CRISPR stocks to buy.
Top 10 CRISPR Stocks to Buy Now
Innovation is a hallmark of the biopharmaceutical sector, which is fueled by the demand for novel therapies to address unresolved medical needs.
CRISPR Therapeutics AG (CRSP): A Bull Case Theory
We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will summarize the bulls’ thesis on CRSP.
Hedge Fund Resource Center
